<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neural Plast</journal-id><journal-id journal-id-type="publisher-id">NP</journal-id><journal-title>Neural Plasticity</journal-title><issn pub-type="epub">1687-5443</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2008/401645</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Role of GLU<sub>K5</sub>-Containing Kainate Receptors in Entorhinal Cortex Gamma Frequency Oscillations</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Stanger</surname><given-names>Heather L.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Alford</surname><given-names>Rebekah</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jane</surname><given-names>David E.</given-names></name><xref ref-type="aff" rid="I3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cunningham</surname><given-names>Mark O.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Institute of Neuroscience, Faculty of Medical Sciences, Newcastle University, The Medical School Framlington Place, Newcastle upon Tyne NE2 4HH, UK</aff><aff id="I2"><sup>2</sup>The Molecular Biology, Biochemistry and Bioinformatics (MB3) Program, Towson University, Room 360, Smith Hall, 8000 York Road, Towson, MD 21251-0001, USA</aff><aff id="I3"><sup>3</sup>Department of Physiology and Pharmacology, MRC Centre for Synaptic Plasticity, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK</aff><author-notes><corresp id="cor1">*Mark O. Cunningham: <email>mark.cunningham@ncl.ac.uk</email></corresp><fn fn-type="other"><p>Recommended by C. Andrew Chapman</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>401645</elocation-id><history><date date-type="received"><day>5</day><month>6</month><year>2008</year></date><date date-type="rev-recd"><day>21</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>9</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Heather L. Stanger et al.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Using in vitro brain slices of hippocampus and cortex, neuronal oscillations in the frequency range of 30&#x02013;80 Hz (gamma frequency oscillations) can be induced by a number of pharmacological manipulations. The most routinely used is the bath application of the broad-spectrum glutamate receptor agonist, kainic acid. In the hippocampus, work using transgenic kainate receptor knockout mice have revealed information about the specific subunit composition of the kainate receptor implicated in the generation and maintenance of the gamma frequency oscillation. However, there is a paucity of such detail regarding gamma frequency oscillation in the cortex. Using specific pharmacological agonists and antagonists for the kainate receptor, we have set out to examine the contribution of kainate receptor subtypes to gamma frequency oscillation in the entorhinal cortex. The findings presented demonstrate that in contrast to the hippocampus, kainate receptors containing the GLU<sub>K5</sub> subunit are critically important for the generation and maintenance of gamma frequency oscillation in the entorhinal cortex. Future work will concentrate on determining the exact nature of the cellular expression of kainate receptors in the entorhinal cortex.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>KARs are made up of various combinations of five subunits: GLU<sub>K5</sub>, GLU<sub>K6</sub>, GLU<sub>K7</sub>, KA1, and KA2 [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>] which are abundantly expressed in the neocortex [<xref ref-type="bibr" rid="B3">3</xref>]. These subunits make up tetramers of either homomeric or heteromeric assemblies, with GLU<sub>K5&#x02013;7</sub> being able to form functional homomeric receptors [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. KA1 and KA2 cannot form functional receptors when expressed alone [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>], yet are able to form functional KARs when expressed heteromerically with other subunits [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>]. Differential patterns of expression of KARs in the CNS coupled with the existence of splice variants and mRNA editing suggest complex neurophysiological roles for the various subunits, and different roles in neuronal networks depending on their localization [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p><p>Of particular interest is the role of KARs in the generation and maintenance of network neuronal oscillatory activity in cortical regions [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. Gamma frequency oscillations occur between 30&#x02013;80 Hz and have been observed in many areas of the brain, including the hippocampus [<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>] and cortical regions [<xref ref-type="bibr" rid="B14">14</xref>&#x02013;<xref ref-type="bibr" rid="B16">16</xref>]. Cortical gamma oscillations are important in higher brain functions, such as learning, memory, and cognition [<xref ref-type="bibr" rid="B17">17</xref>&#x02013;<xref ref-type="bibr" rid="B19">19</xref>], as well as processing of sensorimotor information [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>]. In carrying out these functions, cortical gamma oscillations are implicated in various central processes, including long-term potentiation (LTP) and synaptic plasticity [<xref ref-type="bibr" rid="B21">21</xref>], with important roles in temporal regulation of neuronal activity.</p><p>Gamma frequency oscillations are recordable from the MEC during wakefulness in humans [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>], as well as in vivo in rodents [<xref ref-type="bibr" rid="B12">12</xref>], in vitro from perfused guinea pig brains [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>], and isolated rat brain slices [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>]. These gamma oscillations in the MEC play a role in the formation, processing, storage, and retrieval of memories [<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>]. Previously it has been demonstrated in an in vitro preparation of the MEC that application of nanomolar concentrations of kainate (200&#x02013;400 nM) can induce persistent gamma frequency oscillations [<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>]. Using this in vitro model of MEC gamma frequency oscillations it has been elucidated that this activity is primarily generated by inhibitory-based neuronal networks [<xref ref-type="bibr" rid="B29">29</xref>&#x02013;<xref ref-type="bibr" rid="B31">31</xref>]. A similar mechanism for the generation of gamma frequency activity has been demonstrated in both the hippocampus and neocortex [<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>].</p><p>To date our understanding of the role of the KARs in neuronal network activity has been hampered by a paucity of selective pharmacological agents. The competitive AMPA/KAR antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[<italic>f</italic>]quinoxaline (NBQX), shows little selectivity between AMPA receptors and KARs at high concentrations, yet at low concentrations (1 <italic>&#x003bc;</italic>M) can be used to block AMPA receptors, and isolate KAR responses [<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>]. However, NBQX shows no selectivity between different KAR subunits. The role of GLU<sub>K5</sub> and GLU<sub>K6</sub> subunits in neuronal oscillatory activity in the hippocampus has been previously investigated using receptor knockout mice [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. However, interpretation of work using transgenic models should be viewed in the light of the knowledge that compensatory factors may play a role. The recent development of pharmacological agents with specificity for distinct subunits has led to the possibility of a detailed pharmacological investigation of the role of specific KARs in cortical gamma frequency oscillations. (<italic>S</italic>)-3-(2-Carboxybenzyl)willardiine (UBP302) is a novel selective GLU<sub>K5</sub>-containing KAR antagonist, with activity at both homomeric and heteromeric GLU<sub>K5</sub>-containing receptors [<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>]. The activity of UBP302 on GLU<sub>K7</sub> is controversial, Dolman et al. [<xref ref-type="bibr" rid="B37">37</xref>] showed that UBP296 (racemic form of UBP302) only weakly inhibited [<sup>3</sup>H]kainate binding to human GLU<sub>K7</sub> (K<sub><italic>i</italic></sub> value of 374 &#x000b1; 122 <italic>&#x003bc;</italic>M). However, in an electrophysiological assay UBP302 was found to block rat homomeric GLU<sub>K7</sub> receptors with an IC<sub>50</sub> value of 4 <italic>&#x003bc;</italic>M but at a concentration of 100 <italic>&#x003bc;</italic>M only very weakly blocked rat GLU<sub>K6</sub>/GLU<sub>K7</sub> receptors [<xref ref-type="bibr" rid="B38">38</xref>]. 5-Carboxy-2,4-di-benzamido-benzoic acid (NS3763) is another novel glutamate antagonist, which is selective and noncompetitive for homomeric GLU<sub>K5</sub>-containing KARs [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>]. (<italic>RS</italic>)-2-amino-3-(3-hydroxy-5-tert-butyl-isoxazol-4-yl)propanoic acid (ATPA) is a selective GLU<sub>K5</sub>-containing receptor agonist [<xref ref-type="bibr" rid="B41">41</xref>]. ATPA has been shown to depress excitatory and GABAergic synaptic transmission in the hippocampus [<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>]. However, Cossart et al. [<xref ref-type="bibr" rid="B35">35</xref>] demonstrated that lower concentrations of ATPA could directly depolarise hippocampal GABAergic interneurons leading to increases in the levels of tonic inhibition onto pyramidal neurons. More recently, similar concentrations of ATPA to that used in the Cossart et al. [<xref ref-type="bibr" rid="B35">35</xref>] study have been shown to facilitate both evoked and action potential-independent glutamate release in the neocortex [<xref ref-type="bibr" rid="B44">44</xref>].</p><p>The data presented here demonstrates a role of GLU<sub>K5</sub>-containing KARs in the MEC by examining the contribution of these receptor subtypes to gamma frequency oscillations. Using a pharmacological approach, we have demonstrated that GLU<sub>K5</sub>-containing KARs are important for the maintenance of gamma frequency oscillations in the MEC. Moreover, the selective activation of GLU<sub>K5</sub>-containing KARs can induce persistent gamma frequency oscillations in the MEC. We also demonstrate that it is the specific activation of homomeric GLU<sub>K5</sub>-containing KARs that is important for the generation of gamma frequency oscillations in the MEC.</p></sec><sec sec-type="section" id="sec2"><title>2. MATERIAL AND METHODS</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. Preparation of EC-hippocampal slices</title><p>All procedures involving animals were carried out in accordance with UK Home Office Legislation. Male Wistar rats, weighing &#x0003e;150 grammes, were first anaesthetised by inhalation of the volatile anaesthetic isofluorane. This was immediately followed by intramuscular injection of a terminal dose of &#x02265;100 mg/kg ketamine and &#x02265;10 mg/kg xylazine. After confirmation of deep anaesthesia, rats were intracardiacally perfused with &#x0223c;50 mL sucrose-modified artificial cerebral spinal fluid (aCSF), composed of (in millimolar (mM)): 252 sucrose, 3 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub><italic>&#x000b7;</italic>2H<sub>2</sub>O, 10 glucose, and 24 NaHCO<sub>3</sub>. All salts were obtained from BDH Laboratory Supplies (Poole, UK), except MgSO<sub>4</sub> which was obtained from Sigma Chemical Co (Mo, USA).</p><p>The whole brain was rapidly removed and maintained in a bath of cold sucrose-modified aCSF (4-5&#x000b0;C) during the dissection procedure. Horizontal slices (450 <italic>&#x003bc;</italic>m thick) were cut using a vibroslice (Leica VT1000S). Transverse EC-hippocampal slices were then transferred either to a holding chamber or directly to the recording chamber. They were maintained at 32 &#x000b1; 1&#x000b0;C, at the interface between a continuous perfusion (~2-3 mL/min) of NaCl-based aCSF (containing (in mM): 126 NaCl, 3 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 1 MgSO<sub>4</sub>, 1.2 CaCl<sub>2</sub><italic>&#x000b7;</italic>2H<sub>2</sub>O, 10 glucose, 24 NaHCO<sub>3</sub>) and humidified carbogen gas (95% O<sub>2</sub>/5% CO<sub>2</sub>). Slices were allowed to equilibrate for 60 minutes before any recordings were taken.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Electrophysiological recording and drug application</title><p>Extracellular recordings were taken using glass electrodes pulled from borosilicate glass capillaries (GC129 TF-10, 1.2 mm OD/0.94 mm ID) (Harvard Apparatus, Kent, UK) using a Flaming/Brown micropipette puller, model P-97 (Sutter Instrument Co., Calif, USA). This created electrodes with resistances of 2&#x02013;4 M&#x003a9;. Electrodes were filled with NaCl-based aCSF and positioned in Layer III of the MEC. Control readings were taken from slices before drug application to confirm that any network activity seen following treatment was due to the presence of drugs.</p><p>To evoke gamma frequency oscillations, 400 nM kainic acid ((2<italic>S</italic>,3<italic>S</italic>,4<italic>S</italic>)-3-carboxymethyl-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylic acid; Tocris Cookson, Bristol, UK) was bath applied to EC-hippocampal slices and left to equilibrate for 2-3 hours or until gamma oscillations had stabilised. All other drugs were bath applied to slices at known concentrations: UBP302 ((<italic>S</italic>)-3-(2-carboxybenzyl)willardiine; gift from Dr. David Jane, Department of Pharmacology, University of Bristol, UK) at 10 <italic>&#x003bc;</italic>M; ATPA ((<italic>RS</italic>)-2-amino-3-(3-hydroxy-5-<italic>tert</italic>-butylisoxazol-4-yl)propanoic acid; Tocris Cookson, Bristol, UK) at 1&#x02013;5 <italic>&#x003bc;</italic>M; NS3763 (5-carboxy-2,4-di-benzamido-benzoic acid; Tocris, Bristol, UK) at 10&#x02013;15 <italic>&#x003bc;</italic>M; NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[<italic>f</italic>]quinoxaline; Tocris, Bristol, UK) at 1&#x02013;10 <italic>&#x003bc;</italic>M; and Carbachol (Sigma, UK) at 10&#x02013;20 <italic>&#x003bc;</italic>M.</p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. Data acquisition</title><p>An AppleMac computer with the Axograph OSX software package (AxographX, Dr. John Clements, Australia) was used for all data acquisition. Signals were analogue filtered at 0.01&#x02013;0.3 kHz and then digitized at a frequency of 10 kHz. Power spectra were constructed, where power at a given gamma frequency was defined as the area under the peak between 20 and 80 Hz. Power spectra were generated from digitized data, using 60 second epochs of recorded activity, and it was from these spectra that values for gamma oscillation peak frequency, peak amplitude, and spectral area power in the gamma frequency band were obtained.</p></sec><sec sec-type="subsection" id="subsec2.4"><title>2.4. Data analysis</title><p>Data analysis was carried out using Excel and Kaleidagraph software packages. Kaleidagraph software was used to generate pooled power spectra, and the Excel package was used to calculate the mean and standard error of mean (SEM) of results, and to draw up histograms and line graphs. All data is presented as mean &#x000b1; SEM. SigmaStat (Systat software, USA) was used for all statistical tests. Normality tests were carried out, and if data was found to be normally distributed, two-tailed paired <italic>t-tests</italic> were run. However, if data failed the normality test, the Wilcoxon signed rank test was carried out. This provided us with <italic>P</italic>-values for all data sets, and the significance level was set at 95%; values less than <italic>P</italic> = .05 were deemed to be statistically significant.</p></sec></sec><sec sec-type="section" id="sec3"><title>3. RESULTS</title><sec sec-type="subsection" id="subsec3.1"><title>3.1. Induction of kainate-driven gamma oscillations in the MEC</title><p>Previously, it has been demonstrated that low concentrations of kainic acid (kainate) evoke gamma frequency activity in the rat MEC in vitro [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>]. In this investigation, we produced persistent gamma oscillations in the MEC by bath application of kainate (400 nM) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Robust gamma frequency oscillations (39.4 &#x000b1; 1.6 Hz; <italic>n</italic> = 17) were evoked in layer III of the MEC in all slices to which kainate had been applied (<italic>n</italic> = 17). This activity was generated within 15 minutes of kainate superfusion, a stable baseline was observed after 60&#x02013;90 minutes. As previously reported [<xref ref-type="bibr" rid="B19">19</xref>], application of the competitive AMPA/KAR antagonist NBQX (10 <italic>&#x003bc;</italic>M) effectively abolished these kainate-induced gamma oscillations (<italic>n</italic> = 3) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec sec-type="subsection" id="subsec3.2"><title>3.2. A role for GLU<sub>K5</sub>-containing KARs in the maintenance of kainate-driven gamma oscillations</title><p>A possible role for GLU<sub>K5</sub>-containing KARs in the maintenance of kainate-driven gamma frequency oscillations in the MEC was investigated by testing the ability of the GLU<sub>K5</sub> selective antagonist, UBP302, to inhibit preestablished kainate-induced gamma activity. Gamma oscillations were generated in the MEC by bath application of kainate (400 nM) and allowed to stabilise (<italic>n</italic> = 9) (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>). In the presence of UBP302 (10 <italic>&#x003bc;</italic>M), the amplitude of kainate-induced gamma oscillations was significantly reduced (control, 116.7 &#x000b1; 44.1 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> UBP302, 70.0 &#x000b1; 30.3 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 9), and area power of oscillations was also significantly decreased (control, 1586.0 &#x000b1; 503.3 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> UBP302, 1155.1 &#x000b1; 441.4 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 9) (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>, <xref ref-type="fig" rid="fig2">2(b)</xref>). However, following UBP302 application, the frequency of oscillations remained unchanged (control, 40.4 &#x000b1; 2.1 Hz; <italic>v.</italic> UBP302, 38.9 &#x000b1; 2.6 Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 9). Washout of the effects of UBP302 on gamma frequency oscillations could not be achieved (<italic>n</italic> = 9) (Figures <xref ref-type="fig" rid="fig2">2(a)</xref>, <xref ref-type="fig" rid="fig2">2(b)</xref>).</p></sec><sec sec-type="subsection" id="subsec3.3"><title>3.3. A role for GLU<sub>K5</sub>-containing KARs in the generation of gamma oscillations in the MEC</title><p>To investigate the role that GLU<sub>K5</sub>-containing KARs may play in the induction of kainate-driven gamma oscillations, we carried out two experiments, using the selective GLU<sub>K5</sub>-containing KAR agonist, ATPA, and antagonist, UBP302.</p><p>First, we tested the ability of UBP302 to inhibit the generation of a kainate-driven gamma frequency oscillation in the MEC. Slices were preincubated in UBP302 (10 <italic>&#x003bc;</italic>M) for 30 minutes. As expected, UBP302 administration caused no neuronal network activity in slices (<italic>n</italic> = 11) (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>). However, when kainate was applied to slices following preincubation with UBP302, gamma frequency oscillations were generated in all slices (<italic>n</italic> = 11) (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>). On washout into kainate alone (400 nM), although the frequency of oscillations did not change significantly (in presence of kainate following preincubation with UBP302, 45.4 &#x000b1; 2.0 Hz; <italic>v.</italic> 400 nM kainate alone, 40.3 &#x000b1; 0.9 Hz; <italic>P</italic> &#x0003e; .05; <italic>n</italic> = 11), oscillations were seen to increase significantly in both peak amplitude (in presence of kainate following preincubation with UBP302, 39.2 &#x000b1; 12.1 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> 400 nM kainate alone, 122.9 &#x000b1; 32.8 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 11) and area power (in presence of kainate following preincubation with UBP302, 545.1 &#x000b1; 159.6 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> 400 nM kainate alone, 1302.5 &#x000b1; 241.4 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 11) (Figures <xref ref-type="fig" rid="fig3">3(a)</xref>, <xref ref-type="fig" rid="fig3">3(b)</xref>).</p><p>We next investigated whether gamma frequency oscillations could be generated in the MEC by application of the GLU<sub>K5</sub> selective agonist, ATPA. ATPA was bath applied to slices at concentrations of 1 <italic>&#x003bc;</italic>M, 2 <italic>&#x003bc;</italic>M, and 5 <italic>&#x003bc;</italic>M. ATPA induced gamma frequency oscillations in the MEC in the majority of slices to which the agonist was applied (<italic>n</italic> = 18 out of a total <italic>n</italic> = 26) (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>). Slices showing gamma oscillations upon ATPA application were observed to be dorsal MEC slices. Upon increasing the concentration of ATPA in slices demonstrating gamma oscillations, the mean frequency, peak amplitude, and area power of oscillations increased (<italic>n</italic> = 10) (Figures <xref ref-type="fig" rid="fig4">4(a)</xref>, <xref ref-type="fig" rid="fig4">4(b)</xref>). The frequency of oscillations increased from 23.0 &#x000b1; 1.9 Hz, to 34.0 &#x000b1; 2.4 Hz, and to 44.2 &#x000b1; 1.5 Hz (<italic>n</italic> = 10) (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>), the peak amplitude increased from 0.9 &#x000b1; 0.5 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz, to 4.1 &#x000b1; 2.3 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz, and to 23.3 &#x000b1; 8.7 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz (<italic>n</italic> = 10) (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>), and the power increased from 23.1 &#x000b1; 12.6 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz, to 88.4 &#x000b1; 38.9 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz, and to 201.8 &#x000b1; 71.0 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz, at the respective concentrations of ATPA (1 <italic>&#x003bc;</italic>M, 2 <italic>&#x003bc;</italic>M, and 5 <italic>&#x003bc;</italic>M) (<italic>n</italic> = 10) (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>). Control readings, taken before ATPA administration, showed that no network activity was spontaneously present in slices (<italic>n</italic> = 26) (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>i). ATPA-induced gamma frequency oscillations were susceptible to the AMPA/KAR antagonist NBQX (10 <italic>&#x003bc;</italic>M) (<italic>n</italic> = 3).</p><p>We next investigated the effect of UBP302 on ATPA-induced gamma frequency oscillations in the MEC. Gamma frequency oscillations were induced in slices by bath application of ATPA (2&#x02013;5 <italic>&#x003bc;</italic>M) (<italic>n</italic> = 4) (<xref ref-type="fig" rid="fig5">Figure 5(a)</xref>i). UBP302 (10 <italic>&#x003bc;</italic>M) application caused no significant change in the frequency of gamma oscillations (control, 42.7 &#x000b1; 3.9 Hz; <italic>v.</italic> UBP302, 33.9 &#x000b1; 7.3 Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 4) and yet had significant effects on both the peak amplitude (control, 20.8 &#x000b1; 7.1 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> UBP302, 6.6 &#x000b1; 2.8 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 4) and power of oscillations (control, 359.7 &#x000b1; 117.9 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> UBP302, 141.7 &#x000b1; 61.9 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 4) (Figures <xref ref-type="fig" rid="fig5">5(a)</xref>ii, <xref ref-type="fig" rid="fig5">5(b)</xref>). The effects of UBP302 on an ATPA-induced gamma frequency oscillations were not reversible on washout (<italic>n</italic> = 4).</p></sec><sec sec-type="subsection" id="subsec3.4"><title>3.4. A role for homomeric GLU<sub>K5</sub>-containing KARs in gamma frequency oscillations</title><p>The GLU<sub>K5</sub> selective KAR antagonist, NS3763, was used to investigate the contribution of homomeric GLU<sub>K5</sub>-containing KARs to gamma activity in the MEC. NS3763 selectively antagonises homomeric GLU<sub>K5</sub> KARs [<xref ref-type="bibr" rid="B39">39</xref>] and experiments were carried out to determine the role of these homomeric receptors in both kainate- and ATPA-induced gamma oscillations.</p><p>Application of NS3763 (10&#x02013;15 <italic>&#x003bc;</italic>M) caused significant decreases in both peak amplitude (control, 100.2 &#x000b1; 48.4 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> NS3763, 46.0 &#x000b1; 23.7 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 8) and area power (control, 822.9 &#x000b1; 273.2 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> NS3763, 449.4 &#x000b1; 182.3 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 8) of kainate-induced gamma oscillations in the MEC (Figures <xref ref-type="fig" rid="fig6">6(a)</xref>, <xref ref-type="fig" rid="fig6">6(b)</xref>). However, no effect was seen on the frequency of kainate-generated oscillations (control, 38.3 &#x000b1; 2.7 Hz; <italic>v.</italic> NS3763, 36.0 &#x000b1; 1.5 Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 8) (<xref ref-type="fig" rid="fig6">Figure 6(b)</xref>).</p><p>Application of NS3763 (10&#x02013;15 <italic>&#x003bc;</italic>M) to slices demonstrating ATPA-induced gamma oscillations caused no significant change in the frequency of oscillations (control, 46.7 &#x000b1; 3.8 Hz; <italic>v.</italic> NS3763, 38.5 &#x000b1; 6.2 Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 8) (Figures <xref ref-type="fig" rid="fig7">7(a)</xref>, <xref ref-type="fig" rid="fig7">7(b)</xref>). However, the presence of NS3763 caused a significant decrease in both the peak amplitude (control, 191.9 &#x000b1; 63.1 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> NS3763, 28.5 &#x000b1; 13.6 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 8) and area power (control, 1192.9 &#x000b1; 342.8 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> NS3763, 333.6 &#x000b1; 120.5 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003c; .05; <italic>n</italic> = 8) of gamma oscillations (Figures <xref ref-type="fig" rid="fig7">7(a)</xref>, <xref ref-type="fig" rid="fig7">7(b)</xref>). The effects of NS3763 on either kainate- or ATPA-induced gamma frequency oscillations were not reversible on washout (<italic>n</italic> = 12).</p></sec><sec sec-type="subsection" id="subsec3.5"><title>3.5. A role for GLU<sub>K5</sub>-containing KARs in carbachol-induced gamma oscillations</title><p>Cortical gamma frequency oscillations can also be induced by application of carbachol, an agonist at muscarinic acetylcholine receptors (mAChRs) [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B45">45</xref>&#x02013;<xref ref-type="bibr" rid="B49">49</xref>]. It is unclear as to the role of GLU<sub>K5</sub>-containing KARs in a cholinergic-mediated gamma frequency oscillation in the MEC. Carbachol will cause an increase in the release of glutamate in the form of rhythmic EPSPs [<xref ref-type="bibr" rid="B46">46</xref>]. This, in turn, may lead to activation of KARs [<xref ref-type="bibr" rid="B50">50</xref>]. In agreement with previous studies in the MEC [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>] bath application of carbachol (10&#x02013;20 <italic>&#x003bc;</italic>M) generated persistent gamma frequency oscillations (<italic>n</italic> = 6) (<xref ref-type="fig" rid="fig8">Figure 8(a)</xref>i). Application of UBP302 (10 <italic>&#x003bc;</italic>M) had no significant effect on the frequency (control, 41.7 &#x000b1; 1.6 Hz; <italic>v.</italic> UBP302, 40.3 &#x000b1; 0.6 Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 6), peak amplitude (control, 5.9 &#x000b1; 3.1 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>v.</italic> UBP302, 5.5 &#x000b1; 2.5 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 6) or power (control, 155.2 &#x000b1; 72.7 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>v.</italic> UBP302, 148.7 &#x000b1; 62.8 <italic>&#x003bc;</italic>V<sup>2</sup>/Hz.Hz; <italic>P</italic> &#x0003e; .1; <italic>n</italic> = 6) of preestablished carbachol-driven gamma oscillations (Figures <xref ref-type="fig" rid="fig8">8(a)</xref>ii, <xref ref-type="fig" rid="fig8">8(b)</xref>). This lack of effect was further demonstrated by washout back into carbachol causing no significant change in observed gamma frequency oscillations (Figures <xref ref-type="fig" rid="fig8">8(a)</xref>iii, <xref ref-type="fig" rid="fig8">8(b)</xref>).</p></sec></sec><sec sec-type="section" id="sec4"><title>4. DISCUSSION</title><p>A number of studies have examined the contribution of various KAR subunits to gamma frequency oscillations in the hippocampus in vitro. Fisahn et al. [<xref ref-type="bibr" rid="B10">10</xref>] focused on the roles of GLU<sub>K5</sub> and GLU<sub>K6</sub> subunits in kainate-induced hippocampal gamma oscillations, using brain slices from transgenic GLU<sub>K5</sub> and GLU<sub>K6</sub> receptor knockout mice. Knockout of GLU<sub>K5</sub> caused increased sensitivity of the hippocampal network to the effects of kainate and higher susceptibility to oscillatory and epileptogenic activity. Slices from GLU<sub>K6</sub>-knockout mice could not support kainate-induced gamma oscillations or epileptiform activity, suggesting distinct roles for GLU<sub>K5</sub> and GLU<sub>K6</sub> subunits in the hippocampus. Fisahn et al. [<xref ref-type="bibr" rid="B10">10</xref>] concluded that GLU<sub>K5</sub>-containing receptors may be expressed on axons of hippocampal interneurons and have a function in inhibitory tone, and that GLU<sub>K6</sub>-containing KARs may be found in the somatodendritic region of pyramidal cells and interneurons, and provide excitatory drive. Functional receptors of both subtypes must interact to allow generation of stable gamma oscillations in the hippocampus [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p><p>Subsequently, Brown et al. [<xref ref-type="bibr" rid="B51">51</xref>] used pharmacological approaches to investigate the role of GLU<sub>K5</sub>-containing receptors in hippocampal gamma oscillations. This study used the GLU<sub>K5</sub>-selective agonists ATPA and iodowillardiine but found that neither could induce gamma network activity in area CA3 of rat hippocampal slices. The GLU<sub>K5</sub> selective antagonist, UBP296, when preincubated with hippocampal slices, did not prevent induction of kainate-driven gamma oscillations. However, UBP296 produced an approximately 50% reduction in the power of preestablished kainate-induced gamma frequency oscillations. This paper concluded that GLU<sub>K5</sub>-containing KARs alone cannot generate gamma oscillations in the hippocampus but may be involved in maintenance of hippocampal gamma activity generated through other KAR subtypes.</p><p>In the present study, we have demonstrated that, similarly to in the hippocampus [<xref ref-type="bibr" rid="B51">51</xref>], GLU<sub>K5</sub>-containing KARs in the MEC have a role in the maintenance of kainate-driven oscillations. UBP302, a GLU<sub>K5</sub> selective antagonist, caused reductions in peak amplitude and spectral power of preestablished kainate-induced gamma frequency oscillations in the MEC. Furthermore, pretreatment of slices with UBP302 partially inhibited generation of kainate-induced gamma frequency oscillations, suggesting that GLU<sub>K5</sub>-containing KARs are at least partially responsible for the induction of gamma oscillations by kainate application. These data suggest that in the MEC, differently to in the hippocampus [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>], activation of GLU<sub>K5</sub>-containing KARs plays a role in the ability of MEC neuronal networks to generate gamma frequency oscillations. Moreover, in contrast to hippocampal gamma evoked by kainate, MEC gamma generated with GLU<sub>K5</sub> agonists demonstrates a frequency increment with increased excitatory drive. This may reflect the manifestation of fundamentally different mechanisms of local circuit gamma oscillation generation in these two regions.</p><p>It was not surprising then that application of the GLU<sub>K5</sub> subunit selective agonist ATPA [<xref ref-type="bibr" rid="B41">41</xref>] successfully evoked gamma frequency oscillations in the MEC. However, care must be taken with interpretation of this data as ATPA has recently been shown not to be entirely selective for GLU<sub>K5</sub>-containing KARs [<xref ref-type="bibr" rid="B40">40</xref>]. In fact, ATPA can activate both homomeric and heteromeric KAR complexes containing GLU<sub>K5</sub>, and also GLU<sub>K6</sub>/KA2 heteromeric KARs [<xref ref-type="bibr" rid="B48">48</xref>]. Thus, it cannot initially be assumed that these gamma oscillations have been generated via GLU<sub>K5</sub>-containing receptor complexes, since they could have been induced through GLU<sub>K6</sub>/KA2 heteromeric receptors. UBP302, however, is an antagonist with selectivity for GLU<sub>K5</sub>-containing KARs [<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>]. Whilst UBP302 has been shown to block GLU<sub>K7</sub> with an IC<sub>50</sub> value of 4 <italic>&#x003bc;</italic>M&#x02014;this makes it ~10-fold selective for GLU<sub>K5</sub> versus GLU<sub>K7</sub>&#x02014;it does not have activity on GLU<sub>K6</sub> or GLU<sub>K6</sub>/KA2 up to 100 <italic>&#x003bc;</italic>M. Indeed, some controversy surrounds the activity of UBP302 on GLU<sub>K7</sub> as it has been reported that UBP302 failed to demonstrate any potent activity in a binding assay on GLU<sub>K7</sub> (personal communication, D.E. Jane). In any case, as UBP302 only blocks homomeric GLU<sub>K7</sub> and activation of GLU<sub>K7</sub> requires very high glutamate concentrations (EC<sub>50</sub> value 5.9 mM) [<xref ref-type="bibr" rid="B52">52</xref>] it may not be relevant to this study. Application of UBP302 onto slices showing ATPA-generated network activity causes reduced peak amplitude and an approximately 60% reduction in area power of gamma frequency oscillations. This inhibition of ATPA-generated gamma oscillations by UBP302 suggests that the observed activity must, at least in part, be due to activation of GLU<sub>K5</sub>-containing KARs.</p><p>Moreover, NS3763 application caused a significant reduction in peak amplitude and spectral power of preestablished kainate-driven gamma oscillations. This demonstrates that homomeric GLU<sub>K5</sub>-containing KARs are at least partially responsible for the maintenance of these kainate-driven gamma frequency oscillations. Application of NS3763 to preestablished ATPA-generated oscillations caused an approximately 80% reduction in area power of gamma frequency oscillations and also a reduction in peak amplitude. This suggests that a large component of an ATPA-driven gamma oscillation is maintained through homomeric GLU<sub>K5</sub> KARs. The activity of the selective homomeric GLU<sub>K5</sub>-containing KAR antagonist, NS3763, on both kainate- and ATPA-generated gamma frequency oscillations, tells us that homomeric GLU<sub>K5</sub>-containing KARs are involved in the observed network activity.</p><p>It has been suggested that carbachol-driven activity could cause excess glutamate release and that this overspill of glutamate could activate KARs [<xref ref-type="bibr" rid="B50">50</xref>]. The lack of effect of the GLU<sub>K5</sub> selective antagonist, UBP302, on carbachol-induced gamma oscillations in the MEC suggests that GLU<sub>K5</sub>-containing KARs are not involved in the generation or maintenance of gamma oscillations induced via activation of muscarinic cholinergic receptor. However, we cannot rule out the possibility that other KAR subtypes may be involved in these mAChR-mediated gamma oscillations.</p><p>We have shown that GLU<sub>K5</sub>-containing KARs are implicated in the generation and maintenance of gamma frequency oscillations in the MEC evoked by kainate. However, we can only speculate on the cellular localisation of these GLU<sub>K5</sub>-containing receptors in the MEC. Research performed by Christensen et al. [<xref ref-type="bibr" rid="B40">40</xref>] in the hippocampus, suggested likely localisations of KAR subtypes in hippocampal CA1 inhibitory interneurons terminating with pyramidal cells, concluding that heteromeric GLU<sub>K6</sub>/KA2 receptors are expressed in somatodendritic compartments of interneurons, and that GLU<sub>K5</sub> complexes, with either GLU<sub>K6</sub> or KA2, are found at presynaptic terminals. It seems likely from our results that in the MEC, both homomeric and heteromeric GLU<sub>K5</sub>-containing KARs are present.</p><p>Presynaptic KARs are involved in regulation and modulation of neurotransmitter release at inhibitory and excitatory synapses in the hippocampus [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>]. In contrast, postsynaptic KARs mediate excitatory postsynaptic currents (EPSCs) in many brain regions [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B55">55</xref>]. KAR activation in the hippocampus modulates GABA release at terminals of inhibitory interneurons and causes an increase in spontaneous IPSCs but a reduction in the amplitude of these IPSCs impinging on to CA1 interneurons [<xref ref-type="bibr" rid="B40">40</xref>]. This suggests that KARs may be present in two distinct populations in hippocampal inhibitory interneurons, and the same may be true of KARs in the MEC [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B40">40</xref>]. However, other reports have demonstrated that kainate can increase the frequency and amplitude of spontaneous IPSCs, but not action potential-independent miniature IPSCs in stratum radiatum interneurons [<xref ref-type="bibr" rid="B56">56</xref>]. Moreover, these authors also observed that kainate can directly depolarise the axonal plexus of inhibitory interneurons producing both increased antidromic and presumably orthodromic spiking. This effect would explain the ability of KAR activation to increase spontaneous but not miniature IPSC activity. The presence of KARs at an axonal loci has been well documented in the hippocampus, most notably in mossy fibres [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>].</p><p>As outlined in the previous paragraph, there is a large corpus of data on the role of KAR in the hippocampus. However, with respect to the MEC there is a paucity of such information. In order to put the current results presented in this paper into context, future work will concentrate on combining intracellular recordings from individual neurones (pyramidal and interneuron), specific pharmacological KAR tools, and transgenic KAR subunit knockout animals [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>] to elucidate the exact nature of cellular expression of KARs in the MEC.</p></sec></body><back><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollmann</surname><given-names>M</given-names></name><name><surname>Heinemann</surname><given-names>S</given-names></name></person-group><article-title>Cloned glutamate receptors</article-title><source><italic>Annual Review of Neuroscience</italic></source><year>1994</year><volume>17</volume><fpage>31</fpage><lpage>108</lpage></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lerma</surname><given-names>J</given-names></name><name><surname>Paternain</surname><given-names>AV</given-names></name><name><surname>Rodr&#x000ed;guez-Moreno</surname><given-names>A</given-names></name><name><surname>L&#x000f3;pez-Garc&#x000ed;a</surname><given-names>JC</given-names></name></person-group><article-title>Molecular physiology of kainate receptors</article-title><source><italic>Physiological Reviews</italic></source><year>2001</year><volume>81</volume><issue>3</issue><fpage>971</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">11427689</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisden</surname><given-names>W</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><article-title>A complex mosaic of high-affinity kainate receptors in rat brain</article-title><source><italic>The Journal of Neuroscience</italic></source><year>1993</year><volume>13</volume><issue>8</issue><fpage>3582</fpage><lpage>3598</lpage><pub-id pub-id-type="pmid">8393486</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bettler</surname><given-names>B</given-names></name><name><surname>Mulle</surname><given-names>C</given-names></name></person-group><article-title>Neurotransmitter receptors II. AMPA and kainate receptors</article-title><source><italic>Neuropharmacology</italic></source><year>1995</year><volume>34</volume><issue>2</issue><fpage>123</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">7542368</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>P</given-names></name><name><surname>Voigt</surname><given-names>M</given-names></name><name><surname>Keinanen</surname><given-names>K</given-names></name><name><surname>Wisden</surname><given-names>W</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><article-title>Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells</article-title><source><italic>Nature</italic></source><year>1991</year><volume>351</volume><issue>6329</issue><fpage>742</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">1648176</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herb</surname><given-names>A</given-names></name><name><surname>Burnashev</surname><given-names>N</given-names></name><name><surname>Werner</surname><given-names>P</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name><name><surname>Wisden</surname><given-names>W</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><article-title>The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits</article-title><source><italic>Neuron</italic></source><year>1992</year><volume>8</volume><issue>4</issue><fpage>775</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">1373632</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chittajallu</surname><given-names>R</given-names></name><name><surname>Braithwaite</surname><given-names>SP</given-names></name><name><surname>Clarke</surname><given-names>VRJ</given-names></name><name><surname>Henley</surname><given-names>JM</given-names></name></person-group><article-title>Kainate receptors: subunits, synaptic localization and function</article-title><source><italic>Trends in Pharmacological Sciences</italic></source><year>1999</year><volume>20</volume><issue>1</issue><fpage>26</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10101959</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Mayer</surname><given-names>ML</given-names></name></person-group><article-title>Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7</article-title><source><italic>The Journal of Neuroscience</italic></source><year>1999</year><volume>19</volume><issue>19</issue><fpage>8281</fpage><lpage>8291</lpage><pub-id pub-id-type="pmid">10493729</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisahn</surname><given-names>A</given-names></name></person-group><article-title>Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool</article-title><source><italic>The Journal of Physiology</italic></source><year>2005</year><volume>562</volume><issue>1</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15513934</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisahn</surname><given-names>A</given-names></name><name><surname>Contractor</surname><given-names>A</given-names></name><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name><name><surname>Heinemann</surname><given-names>SF</given-names></name><name><surname>McBain</surname><given-names>CJ</given-names></name></person-group><article-title>Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2004</year><volume>24</volume><issue>43</issue><fpage>9658</fpage><lpage>9668</lpage><pub-id pub-id-type="pmid">15509753</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bragin</surname><given-names>A</given-names></name><name><surname>Jand&#x000f3;</surname><given-names>G</given-names></name><name><surname>N&#x000e1;dasdy</surname><given-names>Z</given-names></name><name><surname>Hetke</surname><given-names>J</given-names></name><name><surname>Wise</surname><given-names>K</given-names></name><name><surname>Buzs&#x000e1;ki</surname><given-names>G</given-names></name></person-group><article-title>Gamma (40&#x02013;100 Hz) oscillation in the hippocampus of the behaving rat</article-title><source><italic>The Journal of Neuroscience</italic></source><year>1995</year><volume>15</volume><issue>1</issue><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">7823151</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chrobak</surname><given-names>JJ</given-names></name><name><surname>Buzs&#x000e1;ki</surname><given-names>G</given-names></name></person-group><article-title>Gamma oscillations in the entorhinal cortex of the freely behaving rat</article-title><source><italic>The Journal of Neuroscience</italic></source><year>1998</year><volume>18</volume><issue>1</issue><fpage>388</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">9412515</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Csicsvari</surname><given-names>J</given-names></name><name><surname>Jamieson</surname><given-names>B</given-names></name><name><surname>Wise</surname><given-names>KD</given-names></name><name><surname>Buzs&#x000e1;ki</surname><given-names>G</given-names></name></person-group><article-title>Mechanisms of gamma oscillations in the hippocampus of the behaving rat</article-title><source><italic>Neuron</italic></source><year>2003</year><volume>37</volume><issue>2</issue><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">12546825</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>AK</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name></person-group><article-title>Temporal binding and the neural correlates of sensory awareness</article-title><source><italic>Trends in Cognitive Sciences</italic></source><year>2001</year><volume>5</volume><issue>1</issue><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">11164732</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>W</given-names></name></person-group><article-title>Synchronization of cortical activity and its putative role in information processing and learning</article-title><source><italic>Annual Review of Physiology</italic></source><year>1993</year><volume>55</volume><fpage>349</fpage><lpage>374</lpage></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>CM</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>P</given-names></name><name><surname>Engel</surname><given-names>AK</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name></person-group><article-title>Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties</article-title><source><italic>Nature</italic></source><year>1989</year><volume>388</volume><issue>6213</issue><fpage>334</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">2922061</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fell</surname><given-names>J</given-names></name><name><surname>Klaver</surname><given-names>P</given-names></name><name><surname>Lehnertz</surname><given-names>K</given-names></name><etal/></person-group><article-title>Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling</article-title><source><italic>Nature Neuroscience</italic></source><year>2001</year><volume>4</volume><issue>12</issue><fpage>1259</fpage><lpage>1264</lpage><pub-id pub-id-type="pmid">11694886</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fell</surname><given-names>J</given-names></name><name><surname>Klaver</surname><given-names>P</given-names></name><name><surname>Elger</surname><given-names>CE</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>G</given-names></name></person-group><article-title>The interaction of rhinal cortex and hippocampus in human declarative memory formation</article-title><source><italic>Reviews in the Neurosciences</italic></source><year>2002</year><volume>13</volume><issue>4</issue><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">12542259</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>D</given-names></name><name><surname>Nikonenko</surname><given-names>I</given-names></name><name><surname>Jourdain</surname><given-names>P</given-names></name><name><surname>Alberi</surname><given-names>S</given-names></name></person-group><article-title>LTP, memory and structural plasticity</article-title><source><italic>Current Molecular Medicine</italic></source><year>2002</year><volume>2</volume><issue>7</issue><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">12420800</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>W</given-names></name><name><surname>Gray</surname><given-names>CM</given-names></name></person-group><article-title>Visual feature integration and the temporal correlation hypothesis</article-title><source><italic>Annual Review of Neuroscience</italic></source><year>1995</year><volume>18</volume><fpage>555</fpage><lpage>586</lpage></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Spruston</surname><given-names>N</given-names></name><name><surname>Soltesz</surname><given-names>I</given-names></name><name><surname>Konnerth</surname><given-names>A</given-names></name><name><surname>Whittington</surname><given-names>MA</given-names></name><name><surname>Jefferys</surname><given-names>JGR</given-names></name></person-group><article-title>Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity</article-title><source><italic>Progress in Neurobiology</italic></source><year>1998</year><volume>55</volume><issue>6</issue><fpage>563</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">9670218</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>N</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Maehara</surname><given-names>T</given-names></name><name><surname>Okubo</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name></person-group><article-title>Enhanced gamma (30&#x02013;150 Hz) frequency in the human medial temporal lobe</article-title><source><italic>Neuroscience</italic></source><year>1999</year><volume>90</volume><issue>4</issue><fpage>1149</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">10338285</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Maehara</surname><given-names>T</given-names></name><name><surname>Hirai</surname><given-names>N</given-names></name><name><surname>Okubo</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name></person-group><article-title>Cortical oscillations in human medial temporal lobe during wakefulness and all-night sleep</article-title><source><italic>Brain Research</italic></source><year>2001</year><volume>891</volume><issue>1-2</issue><fpage>7</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">11164805</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van der Linden</surname><given-names>S</given-names></name><name><surname>Panzica</surname><given-names>F</given-names></name><name><surname>de Curtis</surname><given-names>M</given-names></name></person-group><article-title>Carbachol induces fast oscillations in the medial but not in the lateral entorhinal cortex of the isolated guinea pig brain</article-title><source><italic>Journal of Neurophysiology</italic></source><year>1999</year><volume>82</volume><issue>5</issue><fpage>2441</fpage><lpage>2450</lpage><pub-id pub-id-type="pmid">10561417</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>CT</given-names></name><name><surname>Biella</surname><given-names>G</given-names></name><name><surname>de Curtis</surname><given-names>M</given-names></name></person-group><article-title>Evidence for spatial modules mediated by temporal synchronization of carbachol-induced gamma rhythm in medial entorhinal cortex</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2000</year><volume>20</volume><issue>20</issue><fpage>7846</fpage><lpage>7854</lpage><pub-id pub-id-type="pmid">11027250</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Davies</surname><given-names>CH</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name><name><surname>Kopell</surname><given-names>N</given-names></name><name><surname>Whittington</surname><given-names>MA</given-names></name></person-group><article-title>Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in vitro</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2003</year><volume>23</volume><issue>30</issue><fpage>9761</fpage><lpage>9769</lpage><pub-id pub-id-type="pmid">14586003</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Halliday</surname><given-names>DM</given-names></name><name><surname>Davies</surname><given-names>CH</given-names></name><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name><name><surname>Whittington</surname><given-names>MA</given-names></name></person-group><article-title>Coexistence of gamma and high-frequency oscillations in rat medial entorhinal cortex in vitro</article-title><source><italic>The Journal of Physiology</italic></source><year>2004</year><volume>559</volume><issue>2</issue><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">15254156</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Hunt</surname><given-names>J</given-names></name><name><surname>Middleton</surname><given-names>S</given-names></name><etal/></person-group><article-title>Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2006</year><volume>26</volume><issue>10</issue><fpage>2767</fpage><lpage>2776</lpage><pub-id pub-id-type="pmid">16525056</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>MA</given-names></name><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Jefferys</surname><given-names>JGR</given-names></name></person-group><article-title>Synchronized oscillation in interneuron networks driven by metabotropic glutamate receptor activation</article-title><source><italic>Nature</italic></source><year>1995</year><volume>373</volume><issue>6515</issue><fpage>612</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">7854418</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e1;jos</surname><given-names>N</given-names></name><name><surname>P&#x000e1;lhalini</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>EO</given-names></name><name><surname>N&#x000e8;meth</surname><given-names>B</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name></person-group><article-title>Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2004</year><volume>24</volume><issue>41</issue><fpage>9127</fpage><lpage>9137</lpage><pub-id pub-id-type="pmid">15483131</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gloveli</surname><given-names>T</given-names></name><name><surname>Dugladze</surname><given-names>T</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><etal/></person-group><article-title>Differential involvement of oriens/pyramidale interneurones in hippocampal network oscillations in vitro</article-title><source><italic>The Journal of Physiology</italic></source><year>2005</year><volume>562</volume><issue>1</issue><fpage>131</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">15486016</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>MA</given-names></name><name><surname>Traub</surname><given-names>RD</given-names></name></person-group><article-title><italic>Interneuron Diversity series</italic>: inhibitory interneurons and network oscillations in vitro</article-title><source><italic>Trends in Neurosciences</italic></source><year>2003</year><volume>26</volume><issue>12</issue><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">14624852</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Whittington</surname><given-names>MA</given-names></name><name><surname>Bibbig</surname><given-names>A</given-names></name><etal/></person-group><article-title>A role for fast rhythmic bursting neurons in cortical gamma oscillations in vitro</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2004</year><volume>101</volume><issue>18</issue><fpage>7152</fpage><lpage>7157</lpage><pub-id pub-id-type="pmid">15103017</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bureau</surname><given-names>I</given-names></name><name><surname>Bischoff</surname><given-names>S</given-names></name><name><surname>Heinemann</surname><given-names>SF</given-names></name><name><surname>Mulle</surname><given-names>C</given-names></name></person-group><article-title>Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice</article-title><source><italic>The Journal of Neuroscience</italic></source><year>1999</year><volume>19</volume><issue>2</issue><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">9880586</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cossart</surname><given-names>R</given-names></name><name><surname>Esclapez</surname><given-names>M</given-names></name><name><surname>Hirsch</surname><given-names>JC</given-names></name><name><surname>Bernard</surname><given-names>C</given-names></name><name><surname>Ben-Ari</surname><given-names>Y</given-names></name></person-group><article-title>GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells</article-title><source><italic>Nature Neuroscience</italic></source><year>1998</year><volume>1</volume><issue>6</issue><fpage>470</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">10196544</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>More</surname><given-names>JCA</given-names></name><name><surname>Nistico</surname><given-names>R</given-names></name><name><surname>Dolman</surname><given-names>NP</given-names></name><etal/></person-group><article-title>Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist</article-title><source><italic>Neuropharmacology</italic></source><year>2004</year><volume>47</volume><issue>1</issue><fpage>46</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15165833</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolman</surname><given-names>NP</given-names></name><name><surname>Troop</surname><given-names>HM</given-names></name><name><surname>More</surname><given-names>JCA</given-names></name><etal/></person-group><article-title>Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors</article-title><source><italic>Journal of Medicinal Chemistry</italic></source><year>2005</year><volume>48</volume><issue>24</issue><fpage>7867</fpage><lpage>7881</lpage><pub-id pub-id-type="pmid">16302825</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrais</surname><given-names>D</given-names></name><name><surname>Pineiro</surname><given-names>PS</given-names></name><name><surname>Jane</surname><given-names>DE</given-names></name><name><surname>Mulle</surname><given-names>C</given-names></name></person-group><article-title>Antagonism of recombinant and native GluR7-containing receptors: new tools to study presynaptic kainate receptors</article-title><comment>submitted to <italic>Neuropharmacology</italic></comment></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>JK</given-names></name><name><surname>Varming</surname><given-names>T</given-names></name><name><surname>Ahring</surname><given-names>PK</given-names></name><name><surname>Jorgensen</surname><given-names>TD</given-names></name><name><surname>Nielsen</surname><given-names>EO</given-names></name></person-group><article-title>In vitro characterisation of 5-carbozyl-2,4-di-benzamido-benzoic acid (NS3763), a non-competitive antagonist of GLU<sub>K5</sub> receptors</article-title><source><italic>The Journal of Pharmacology and Experimental Theraputics</italic></source><year>2004</year><volume>309</volume><fpage>1003</fpage><lpage>1010</lpage></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>JK</given-names></name><name><surname>Paternain</surname><given-names>AV</given-names></name><name><surname>Selak</surname><given-names>S</given-names></name><name><surname>Ahring</surname><given-names>PK</given-names></name><name><surname>Lerma</surname><given-names>J</given-names></name></person-group><article-title>A mosaic of functional kainate receptors in hippocampal interneurons</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2004</year><volume>24</volume><issue>41</issue><fpage>8986</fpage><lpage>8993</lpage><pub-id pub-id-type="pmid">15483117</pub-id></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>VRJ</given-names></name><name><surname>Ballyk</surname><given-names>BA</given-names></name><name><surname>Hoo</surname><given-names>KH</given-names></name><etal/></person-group><article-title>A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission</article-title><source><italic>Nature</italic></source><year>1997</year><volume>389</volume><issue>6651</issue><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">9335499</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>VRJ</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><article-title>Characterisation of the effects of ATPA, a GLU<sub>K5</sub> receptor selective agonist, on excitatory synaptic transmission in area CA1 of rat hippocampal slices</article-title><source><italic>Neuropharmacology</italic></source><year>2002</year><volume>42</volume><issue>7</issue><fpage>889</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">12069899</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>VRJ</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><article-title>Characterisation of the effects of ATPA, a GLU<sub>K5</sub> kainate receptor agonist, on GABAergic synaptic transmission in the CA1 region of rat hippocampal slices</article-title><source><italic>Neuropharmacology</italic></source><year>2004</year><volume>47</volume><issue>3</issue><fpage>363</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">15275825</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>SL</given-names></name><name><surname>Mathew</surname><given-names>SS</given-names></name><name><surname>Hablitz</surname><given-names>JJ</given-names></name></person-group><article-title>Pre- and postsynaptic effects of kainate on layer II/III pyramidal cells in rat neocortex</article-title><source><italic>Neuropharmacology</italic></source><year>2007</year><volume>53</volume><issue>1</issue><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17543353</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisahn</surname><given-names>A</given-names></name><name><surname>Pike</surname><given-names>FG</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name></person-group><article-title>Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro</article-title><source><italic>Nature</italic></source><year>1998</year><volume>394</volume><issue>6689</issue><fpage>186</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">9671302</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Traub</surname><given-names>RD</given-names></name><name><surname>Bibbig</surname><given-names>A</given-names></name><name><surname>Fisahn</surname><given-names>A</given-names></name><name><surname>Lebeau</surname><given-names>FEN</given-names></name><name><surname>Whittington</surname><given-names>MA</given-names></name><name><surname>Buhl</surname><given-names>EH</given-names></name></person-group><article-title>A model of gamma-frequency network oscillations induced in the rat CA3 region by carbachol in vitro</article-title><source><italic>European Journal of Neuroscience</italic></source><year>2000</year><volume>12</volume><issue>11</issue><fpage>4093</fpage><lpage>4106</lpage><pub-id pub-id-type="pmid">11069606</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hormuzdi</surname><given-names>SG</given-names></name><name><surname>Pais</surname><given-names>I</given-names></name><name><surname>LeBeau</surname><given-names>FEN</given-names></name><etal/></person-group><article-title>Impaired electrical signaling disrupts gamma frequency oscillations in connexin 36-deficient mice</article-title><source><italic>Neuron</italic></source><year>2001</year><volume>31</volume><issue>3</issue><fpage>487</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">11516404</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e1;lhalmi</surname><given-names>J</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name><name><surname>Freund</surname><given-names>TF</given-names></name><name><surname>H&#x000e1;jos</surname><given-names>N</given-names></name></person-group><article-title>Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices</article-title><source><italic>Neuropharmacology</italic></source><year>2004</year><volume>47</volume><issue>3</issue><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">15275827</pub-id></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>EO</given-names></name><name><surname>Suckling</surname><given-names>JM</given-names></name><name><surname>Hajos</surname><given-names>N</given-names></name><name><surname>Greenfield</surname><given-names>SA</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name></person-group><article-title>Perisomatic feedback inhibition underlies cholinergically induced fast network oscillations in the rat hippocampus in vitro</article-title><source><italic>Neuron</italic></source><year>2005</year><volume>45</volume><issue>1</issue><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">15629706</pub-id></citation></ref><ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauri</surname><given-names>SE</given-names></name><name><surname>Segerstr&#x000e5;le</surname><given-names>M</given-names></name><name><surname>Vesikansa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2005</year><volume>25</volume><issue>18</issue><fpage>4473</fpage><lpage>4484</lpage><pub-id pub-id-type="pmid">15872094</pub-id></citation></ref><ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JT</given-names></name><name><surname>Teriakidis</surname><given-names>A</given-names></name><name><surname>Randall</surname><given-names>AD</given-names></name></person-group><article-title>A pharmacological investigation of the role of GLU<sub>K5</sub>-containing receptors in kainate-driven hippocampal gamma band oscillations</article-title><source><italic>Neuropharmacology</italic></source><year>2006</year><volume>50</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">16153668</pub-id></citation></ref><ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schiffer</surname><given-names>HH</given-names></name><name><surname>Swanson</surname><given-names>GT</given-names></name><name><surname>Heinemann</surname><given-names>SF</given-names></name></person-group><article-title>Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate</article-title><source><italic>Neuron</italic></source><year>1997</year><volume>19</volume><issue>5</issue><fpage>1141</fpage><lpage>1146</lpage><pub-id pub-id-type="pmid">9390526</pub-id></citation></ref><ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Contractor</surname><given-names>A</given-names></name><name><surname>Swanson</surname><given-names>G</given-names></name><name><surname>Heinemann</surname><given-names>SF</given-names></name></person-group><article-title>Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus</article-title><source><italic>Neuron</italic></source><year>2001</year><volume>29</volume><issue>1</issue><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">11182092</pub-id></citation></ref><ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Contractor</surname><given-names>A</given-names></name><name><surname>Sailer</surname><given-names>AW</given-names></name><name><surname>Darstein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Loss of kainate receptor-mediated heterosynaptic facilitation of mossy-fiber synapses in KA2<sup>&#x02212;/&#x02212;</sup> mice</article-title><source><italic>The Journal of Neuroscience</italic></source><year>2003</year><volume>23</volume><issue>2</issue><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">12533602</pub-id></citation></ref><ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vignes</surname><given-names>M</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><article-title>The synaptic activation of kainate receptors</article-title><source><italic>Nature</italic></source><year>1997</year><volume>388</volume><issue>6638</issue><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">9217158</pub-id></citation></ref><ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semyanov</surname><given-names>A</given-names></name><name><surname>Kullmann</surname><given-names>DM</given-names></name></person-group><article-title>Kainate receptor-dependent axonal depolarization and action potential initiation in interneurons</article-title><source><italic>Nature Neuroscience</italic></source><year>2001</year><volume>4</volume><issue>7</issue><fpage>718</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">11426228</pub-id></citation></ref><ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>H</given-names></name><name><surname>Ozawa</surname><given-names>S</given-names></name></person-group><article-title>Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse</article-title><source><italic>The Journal of Physiology</italic></source><year>2000</year><volume>523</volume><issue>3</issue><fpage>653</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">10718745</pub-id></citation></ref><ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>D</given-names></name><name><surname>Frerking</surname><given-names>M</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><article-title>Synaptic activation of presynaptic kainate receptors on hippocampal mossy fiber synapses</article-title><source><italic>Neuron</italic></source><year>2000</year><volume>27</volume><issue>2</issue><fpage>327</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">10985352</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p> Gamma frequency oscillations can be induced in layer III of the MEC by application of kainate. (a) Extracellular field recordings showing 1 second epochs of activity (i) in control setting, (ii) following application of 400 nM kainate, and (iii) following application of 10 <italic>&#x003bc;</italic>M NBQX in the presence of 400 nM kainate. Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p> Antagonizing GLU<sub>K5</sub>-containing KARs with UBP302 inhibits kainate-driven gamma frequency oscillations in the MEC. (a) Extracellular field recordings showing 1 second epochs of activity (i) in the presence of 400 nM kainate, (ii) following 10 <italic>&#x003bc;</italic>M UBP302 application, and (iii) during a washout period into 400 nM kainate. (b) Pooled power spectra (<italic>n</italic> = 9) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), a recording in the presence of 400 nM kainate (blue), application of 10 <italic>&#x003bc;</italic>M UBP302 (green), and washout back into 400 nM kainate (red). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.002"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p> Preincubation of slices in UBP302 inhibits the ability of the MEC network to produce kainate-driven gamma frequency oscillations. (a) Extracellular field recordings showing 1 second epochs of activity (i) following preincubation with 10 <italic>&#x003bc;</italic>M UBP302, (ii) following application of 400 nM kainate onto preincubated slices, and (iii) during a washout period into 400 nM kainate. (b) Pooled power spectra (<italic>n</italic> = 11) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), a recording following 10 <italic>&#x003bc;</italic>M UBP302 preincubation (blue), 400 nM kainate application following preincubation (green), and washout into 400 nM kainate (red). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.003"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p> Activation of GLU<sub>K5</sub>-containing KARs can induce gamma frequency oscillations in the MEC. (a) Extracellular field recordings showing 1 second epochs of activity in a control setting (i) following application of 1 <italic>&#x003bc;</italic>M, (ii) 2 <italic>&#x003bc;</italic>M (iii), and 5 <italic>&#x003bc;</italic>M ATPA (iv). (b) Pooled line graphs (<italic>n</italic> = 10) demonstrating the effects of varying ATPA concentration on (i) frequency, (ii) area power, and (iii) peak amplitude of gamma oscillations in the MEC. Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.004"/></fig><fig id="fig5" position="float"><label>Figure 5</label><caption><p> ATPA-generated gamma frequency oscillations in the MEC are reduced by application of the GLU<sub>K5</sub> selective antagonist, UBP302. (a) Extracellular field recordings showing 1 second epochs of activity (i) in the presence of 5 <italic>&#x003bc;</italic>M ATPA and (ii) following application of 10 <italic>&#x003bc;</italic>M UBP302. (b) Pooled power spectra (<italic>n</italic> = 4) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), recording in the presence of 5 <italic>&#x003bc;</italic>M ATPA (blue), and application of 10 <italic>&#x003bc;</italic>M UBP302 (green). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.005"/></fig><fig id="fig6" position="float"><label>Figure 6</label><caption><p> Blocking homomeric GLU<sub>K5</sub>-containing KARs significantly reduces kainate-driven gamma frequency oscillations in the MEC. (a) Extracellular field recordings showing 1 second epochs of activity (i) in the presence of 400 nM kainate and (ii) following application of 10 <italic>&#x003bc;</italic>M NS3763. (b) Pooled power spectra (<italic>n</italic> = 8) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), recording in the presence of 400 nM kainate (blue), application of 10 <italic>&#x003bc;</italic>M NS3763 (green), and a washout back into 400 nM kainate (red). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.006"/></fig><fig id="fig7" position="float"><label>Figure 7</label><caption><p> Blocking homomeric GLU<sub>K5</sub>-containing KARs effectively reduces power and amplitude of ATPA-generated gamma frequency oscillations in the MEC (a) Extracellular field recordings showing 1 second epochs of activity (i) in the presence of 5 <italic>&#x003bc;</italic>M ATPA and (ii) following application of 15 <italic>&#x003bc;</italic>M NS3763. (b) Pooled power spectra (<italic>n</italic> = 4) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), recording in the presence of 5 <italic>&#x003bc;</italic>M ATPA (blue), and application of 15 <italic>&#x003bc;</italic>M NS3763 (green). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.007"/></fig><fig id="fig8" position="float"><label>Figure 8</label><caption><p> Carbachol-induced gamma frequency oscillations are not dependent on GLU<sub>K5</sub>-containing KARs. (a) Extracellular field recordings showing 1 second epochs of activity (i) in the presence of 20 <italic>&#x003bc;</italic>M carbachol, (ii) following 10 <italic>&#x003bc;</italic>M UBP302 application, and (iii) during a washout period into 20 <italic>&#x003bc;</italic>M carbcahol. (b) Pooled power spectra (<italic>n</italic> = 6) produced from 60 second epochs of extracellular field recorded data, showing a control recording (black), recording in the presence of 20 <italic>&#x003bc;</italic>M carbachol (blue), application of 10 <italic>&#x003bc;</italic>M UBP302 (green), and washout back into 20 <italic>&#x003bc;</italic>M carbachol (red). Scale bar represents 200 milliseconds and 100 <italic>&#x003bc;</italic>V.</p></caption><graphic xlink:href="NP2008-401645.008"/></fig></floats-wrap></article> 